Cefepime Hydrochloride; Enmetazobactam is used for treating complicated urinary tract infections (CUTI) including pyelonephritis caused by designated susceptible microorganisms. It was first introduced by Allecra Therapeutics Sas in its drug Exblifep on Feb 22, 2024.

Cefepime Hydrochloride; Enmetazobactam Patents

Given below is the list of patents protecting Cefepime Hydrochloride; Enmetazobactam, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Exblifep	US11124526	Crystalline beta-lactamase inhibitor	Nov 07, 2034	Allecra Theraps
Exblifep	US7687488	2-substituted methyl penam derivatives	Dec 03, 2027	Allecra Theraps

Add above patents to watchlist

Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳